Video Interview: How to achieve a more robust supply chain

Watch Now Will your supply chain hold up to extreme weather? Pandemics? Civil unrest? Catastrophic events have led…

Roundtable Discussion – Which International Markets Can we Anticipate Significant Developments?

Great insights shared by market leaders at Pharma’s Almanac roundtable discussion. Click HERE to access the full summary.

The Future of Biopharma

The Chemical Engineering magazine has published its third article of the biopharmaceutical manufacturing series, written by David Gemmell….

Vaccines Webinar 1st December 2022

Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing: an innovative solution

This webinar describes the collaboration of

Merck KGaA, Darmstadt, Germany
MilliporeSigma
, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion.

The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!

Women-led startups in the US received just 2.3% of VC funding in 2020, yet 40% of US businesses…

Bootcamp Winner Fusix Biotech GmbH visiting M Lab™ Collaboration Center

Biotech Bootcamp winner Fusix Biotech GmbH in interview

The Biotech Bootcamp, which is run in partnership with SmiLe and BioM, provides valuable support in a group…

Biopharmaceutical Manufacturing: An Evolving Industry

Chemical Engineering Magazine has published its second article of the biopharmaceutical manufacturing series, written by Biomanufacturing Engineer, David…

On Demand Webinar: Accelerating the Development of a Virus-Like-Particle Vaccine against COVID-19

Insights from a Global Collaboration Accelerating Vaccine Development with an Optimized VLP Platform The COVID-19 pandemic further emphasized…

Navigating The Regulatory Maze: Fundamentals for Drug Development

Navigating through the evolving regulatory landscape can be a challenge, especially for early-stage biotechnology companies developing a drug…

Planning for CEO Succession of Your Life Science Start-Up

In life science start-ups, we know that one thing is likely (aside from death and taxes): At some…

Scroll to Top